We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.00 | -0.60% | 1,001.50 | 1,000.50 | 1,001.00 | 1,005.50 | 996.40 | 1,001.00 | 1,764,791 | 16:35:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3011 | 33.24 | 8.74B |
From May 2019 to May 2024
TIDMSN.
RNS Number : 0889Y
Smith & Nephew Plc
07 May 2019
7 May 2019
Smith & Nephew plc
Change of Registered Office
Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that with effect from Friday 3 May 2019, the location of its registered office has changed to: Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, WD18 8YE, England.
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: 01923 477216
ENDS
Enquiries
Investors
Andrew Swift +44 (0) 20 7960 2285
Smith & Nephew
Media
Charles Reynolds +44 (0) 1923 477314
Smith & Nephew
About Smith & Nephew
Smith & Nephew is a portfolio medical technology business with leadership positions in Orthopaedics, Advanced Wound Management and Sports Medicine. Smith & Nephew has more than 16,000 employees and a presence in more than 100 countries. Annual sales in 2018 were $4.9 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN). For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com and follow us on Twitter, LinkedIn or Facebook.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
CROEXLFBKEFFBBL
(END) Dow Jones Newswires
May 07, 2019 05:00 ET (09:00 GMT)
1 Year Smith & Nephew Chart |
1 Month Smith & Nephew Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
